Bumrungrad Hospital Past Earnings Performance
Past criteria checks 5/6
Bumrungrad Hospital has been growing earnings at an average annual rate of 26.4%, while the Healthcare industry saw earnings growing at 14% annually. Revenues have been growing at an average rate of 11.6% per year. Bumrungrad Hospital's return on equity is 29.9%, and it has net margins of 29%.
Key information
26.4%
Earnings growth rate
24.2%
EPS growth rate
Healthcare Industry Growth | 23.6% |
Revenue growth rate | 11.6% |
Return on equity | 29.9% |
Net Margin | 29.0% |
Next Earnings Update | 07 Nov 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Bumrungrad Hospital makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 26,211 | 7,592 | 4,207 | 0 |
31 Mar 24 | 26,022 | 7,408 | 4,187 | 0 |
31 Dec 23 | 25,547 | 7,006 | 4,180 | 0 |
30 Sep 23 | 25,069 | 6,832 | 4,086 | 0 |
30 Jun 23 | 24,038 | 6,378 | 4,046 | 0 |
31 Mar 23 | 22,846 | 5,797 | 3,946 | 0 |
31 Dec 22 | 20,908 | 4,938 | 3,798 | 0 |
30 Sep 22 | 18,762 | 4,004 | 3,588 | 0 |
30 Jun 22 | 16,012 | 2,799 | 3,401 | 0 |
31 Mar 22 | 14,078 | 1,850 | 3,349 | 0 |
31 Dec 21 | 12,605 | 1,216 | 3,296 | 0 |
30 Sep 21 | 11,630 | 777 | 3,318 | 0 |
30 Jun 21 | 11,554 | 702 | 3,333 | 0 |
31 Mar 21 | 10,991 | 530 | 3,293 | 0 |
31 Dec 20 | 12,440 | 1,204 | 3,394 | 0 |
30 Sep 20 | 14,169 | 1,917 | 3,548 | 0 |
30 Jun 20 | 16,057 | 2,751 | 3,643 | 0 |
31 Mar 20 | 17,954 | 3,432 | 3,784 | 0 |
31 Dec 19 | 18,559 | 3,748 | 3,751 | 0 |
30 Sep 19 | 18,660 | 3,834 | 3,643 | 0 |
30 Jun 19 | 18,620 | 3,908 | 3,579 | 0 |
31 Mar 19 | 18,580 | 4,154 | 3,401 | 0 |
31 Dec 18 | 18,541 | 4,152 | 3,288 | 0 |
30 Sep 18 | 18,362 | 4,103 | 3,193 | 0 |
30 Jun 18 | 18,435 | 4,029 | 3,139 | 0 |
31 Mar 18 | 18,533 | 4,018 | 3,095 | 0 |
31 Dec 17 | 18,272 | 3,944 | 3,048 | 0 |
30 Sep 17 | 18,053 | 3,846 | 3,038 | 0 |
30 Jun 17 | 17,857 | 3,756 | 3,029 | 0 |
31 Mar 17 | 17,848 | 3,654 | 3,071 | 0 |
31 Dec 16 | 18,103 | 3,626 | 3,125 | 0 |
30 Sep 16 | 18,335 | 3,570 | 3,170 | 0 |
30 Jun 16 | 18,076 | 3,448 | 3,129 | 0 |
31 Mar 16 | 18,128 | 3,439 | 3,094 | 0 |
31 Dec 15 | 17,883 | 3,436 | 3,020 | 0 |
30 Sep 15 | 17,509 | 3,355 | 2,933 | 0 |
30 Jun 15 | 17,248 | 3,280 | 2,859 | 0 |
31 Mar 15 | 16,637 | 3,066 | 2,824 | 0 |
31 Dec 14 | 15,864 | 2,730 | 2,806 | 0 |
30 Sep 14 | 15,355 | 2,668 | 2,781 | 0 |
30 Jun 14 | 14,973 | 2,603 | 2,694 | 0 |
31 Mar 14 | 14,714 | 2,547 | 2,612 | 0 |
31 Dec 13 | 14,597 | 2,521 | 2,527 | 0 |
Quality Earnings: BH-R has high quality earnings.
Growing Profit Margin: BH-R's current net profit margins (29%) are higher than last year (26.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: BH-R's earnings have grown significantly by 26.4% per year over the past 5 years.
Accelerating Growth: BH-R's earnings growth over the past year (19%) is below its 5-year average (26.4% per year).
Earnings vs Industry: BH-R earnings growth over the past year (19%) exceeded the Healthcare industry 16.7%.
Return on Equity
High ROE: BH-R's Return on Equity (29.9%) is considered high.